Cancer Care Ontario | Action Cancer Ontario

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

240 Results

Guidelines and Advice

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Status: Archived
ID: 12-6

Dec 1969

Guidelines and Advice

The Role of Neurokinin-1 Receptor Antagonists in the Prevention of Emesis due to High-dose Cisplatin

Status: Archived
ID: 12-4

Dec 1969

Guidelines and Advice

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Status: Archived
ID: 12-3

Jan 2003

Guidelines and Advice

The Role of Colony-Stimulating Factor (CSF) in Patients Receiving Myelosuppressive Chemotherapy for the Treatment of Cancer

Status: Archived
ID: 12-2 Version 2.2003
Version: 2

Dec 1969

Guidelines and Advice

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Status: Archived
ID: 2-10

Sep 2011

Guidelines and Advice

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-16

Sep 2011

Guidelines and Advice

Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer

Status: Archived
ID: 2-16b
Version: 2

Sep 2011

Guidelines and Advice

Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer

Status: Archived
ID: 2-17

Sep 2011

Guidelines and Advice

The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

Status: Archived
ID: 2-18

Dec 1969

Guidelines and Advice

The Role of Oxaliplatin Combined with 5-Fluorouracil and Folinic Acid in the First and Second-line Treatment of Advanced Colorectal Cancer

Status: Archived
ID: 2-22

Sep 2011

Guidelines and Advice

The Role of Bevacizumab (Avastin®) Combined with Chemotherapy in the Treatment of Patients with Advanced Colorectal Cancer

Status: Archived
ID: 2-25

Dec 1969

Guidelines and Advice

The Use of Conformal Radiotherapy and the Selection of Radiation Dose in T1 or T2 Prostate Cancer

Status: Archived
ID: 3-11

Jan 2012

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

The Role of Neurokinin-1 Receptor Antagonists in the Prevention of Emesis due to High-dose Cisplatin

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

The Role of Colony-Stimulating Factor (CSF) in Patients Receiving Myelosuppressive Chemotherapy for the Treatment of Cancer

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer

Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer

The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

The Role of Oxaliplatin Combined with 5-Fluorouracil and Folinic Acid in the First and Second-line Treatment of Advanced Colorectal Cancer

The Role of Bevacizumab (Avastin®) Combined with Chemotherapy in the Treatment of Patients with Advanced Colorectal Cancer

The Use of Conformal Radiotherapy and the Selection of Radiation Dose in T1 or T2 Prostate Cancer

Pages